299 related articles for article (PubMed ID: 18668437)
21. Residue 33 of human equilibrative nucleoside transporter 2 is a functionally important component of both the dipyridamole and nucleoside binding sites.
Visser F; Zhang J; Raborn RT; Baldwin SA; Young JD; Cass CE
Mol Pharmacol; 2005 Apr; 67(4):1291-8. PubMed ID: 15644498
[TBL] [Abstract][Full Text] [Related]
22. Dipyridamole analogs as pharmacological inhibitors of equilibrative nucleoside transporters. Identification of novel potent and selective inhibitors of the adenosine transporter function of human equilibrative nucleoside transporter 4 (hENT4).
Wang C; Lin W; Playa H; Sun S; Cameron K; Buolamwini JK
Biochem Pharmacol; 2013 Dec; 86(11):1531-40. PubMed ID: 24021350
[TBL] [Abstract][Full Text] [Related]
23. Cloning and characterisation of the Equilibrative Nucleoside Transporter family of Trypanosoma cruzi: ultra-high affinity and selectivity to survive in the intracellular niche.
Campagnaro GD; de Freitas Nascimento J; Girard RBM; Silber AM; de Koning HP
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2750-2763. PubMed ID: 30251664
[TBL] [Abstract][Full Text] [Related]
24. Identification of a nucleoside/nucleobase transporter from Plasmodium falciparum, a novel target for anti-malarial chemotherapy.
Parker MD; Hyde RJ; Yao SY; McRobert L; Cass CE; Young JD; McConkey GA; Baldwin SA
Biochem J; 2000 Jul; 349(Pt 1):67-75. PubMed ID: 10861212
[TBL] [Abstract][Full Text] [Related]
25. Transporters that translocate nucleosides and structural similar drugs: structural requirements for substrate recognition.
Cano-Soldado P; Pastor-Anglada M
Med Res Rev; 2012 Mar; 32(2):428-57. PubMed ID: 21287570
[TBL] [Abstract][Full Text] [Related]
26. Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system.
Jennings LL; Hao C; Cabrita MA; Vickers MF; Baldwin SA; Young JD; Cass CE
Neuropharmacology; 2001 Apr; 40(5):722-31. PubMed ID: 11311901
[TBL] [Abstract][Full Text] [Related]
27. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
Deniskin R; Frame IJ; Sosa Y; Akabas MH
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
[TBL] [Abstract][Full Text] [Related]
28. Nucleoside transporter proteins.
Molina-Arcas M; Casado FJ; Pastor-Anglada M
Curr Vasc Pharmacol; 2009 Oct; 7(4):426-34. PubMed ID: 19485885
[TBL] [Abstract][Full Text] [Related]
29. Expression and hepatobiliary transport characteristics of the concentrative and equilibrative nucleoside transporters in sandwich-cultured human hepatocytes.
Govindarajan R; Endres CJ; Whittington D; LeCluyse E; Pastor-Anglada M; Tse CM; Unadkat JD
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G570-80. PubMed ID: 18635603
[TBL] [Abstract][Full Text] [Related]
30. Functional characterization of human equilibrative nucleoside transporter 1.
Huang W; Zeng X; Shi Y; Liu M
Protein Cell; 2017 Apr; 8(4):284-295. PubMed ID: 27995448
[TBL] [Abstract][Full Text] [Related]
31. Characterization of mammalian equilibrative nucleoside transporters (ENTs) by mass spectrometry.
Reyes G; Naydenova Z; Abdulla P; Chalsev M; Villani A; Rose JB; Chaudary N; DeSouza L; Siu KW; Coe IR
Protein Expr Purif; 2010 Sep; 73(1):1-9. PubMed ID: 20399865
[TBL] [Abstract][Full Text] [Related]
32. Molecular Basis of Nucleobase Transport Systems in Mammals.
Inoue K
Biol Pharm Bull; 2017; 40(8):1130-1138. PubMed ID: 28768993
[TBL] [Abstract][Full Text] [Related]
33. Expression and purification of human and Saccharomyces cerevisiae equilibrative nucleoside transporters.
Boswell-Casteel RC; Johnson JM; Roe-Žurž Z; Duggan KD; Schmitz H; Hays FA
Protein Expr Purif; 2018 Feb; 142():68-74. PubMed ID: 28918196
[TBL] [Abstract][Full Text] [Related]
34. Functional Characterization of the Saccharomyces cerevisiae Equilibrative Nucleoside Transporter 1 (ScENT1).
Boswell-Casteel RC; Johnson JM; Hays FA
Molecules; 2018 Mar; 23(4):. PubMed ID: 29565807
[TBL] [Abstract][Full Text] [Related]
35. Adenosine transport by plasma membrane monoamine transporter: reinvestigation and comparison with organic cations.
Zhou M; Duan H; Engel K; Xia L; Wang J
Drug Metab Dispos; 2010 Oct; 38(10):1798-805. PubMed ID: 20592246
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in studies on biochemical and structural properties of equilibrative and concentrative nucleoside transporters.
Podgorska M; Kocbuch K; Pawelczyk T
Acta Biochim Pol; 2005; 52(4):749-58. PubMed ID: 16265592
[TBL] [Abstract][Full Text] [Related]
37. Nucleoside Transport and Nucleobase Uptake Null Mutants in
Aldfer MM; AlSiari TA; Elati HAA; Natto MJ; Alfayez IA; Campagnaro GD; Sani B; Burchmore RJS; Diallinas G; De Koning HP
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897714
[TBL] [Abstract][Full Text] [Related]
38. Molecular requirements of the human nucleoside transporters hCNT1, hCNT2, and hENT1.
Chang C; Swaan PW; Ngo LY; Lum PY; Patil SD; Unadkat JD
Mol Pharmacol; 2004 Mar; 65(3):558-70. PubMed ID: 14978234
[TBL] [Abstract][Full Text] [Related]
39. Identification of Structural and Molecular Features Involved in the Transport of 3'-Deoxy-Nucleoside Analogs by Human Equilibrative Nucleoside Transporter 3.
Rahman MF; Raj R; Govindarajan R
Drug Metab Dispos; 2018 May; 46(5):600-609. PubMed ID: 29530865
[TBL] [Abstract][Full Text] [Related]
40. Bidirectional transport of 2-chloroadenosine by equilibrative nucleoside transporter 4 (hENT4): Evidence for allosteric kinetics at acidic pH.
Tandio D; Vilas G; Hammond JR
Sci Rep; 2019 Sep; 9(1):13555. PubMed ID: 31537831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
